Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights

Category:

Friday, May 16, 2014 8:00 am EDT

Dateline:

NEW YORK

Public Company Information:

NYSE:
BMY

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Monday, June 2, 2014, at 8 a.m. EDT (7 a.m. CDT) to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s immuno-oncology portfolio, and address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at: http://investor.bms.com or by dialing 913-312-0946, confirmation code: 6785698. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 11 a.m. EDT on June 2 through 11 a.m. EDT on June 16. The replay can be accessed at http://investor.bms.com or by dialing 402-280-9013, confirmation code: 6785698.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Contact:

Bristol-Myers Squibb
Media:
Laura Hortas, 609-252-4587
laura.hortas@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com
or
Ranya Dajani, 609-252-5330
ranya.dajani@bms.com
or
Ryan Asay, 609-252-5020
ryan.asay@bms.com

Search Press Releases

Reset



Subscribe to E-Mail Alerts

Business Wire NewsHQ℠